Sanofi

News

Celebrations for ASMD community as EU clears Sanofi's Xenpoz...

Sanofi has claimed approval in the EU for Xenpozyme as a treatment for acid sphingomyelinase deficiency (ASMD) – which becomes the first and only treatment option for patients with the rare

News

Sanofi extends Health2Sync digital diabetes partnership to J...

Digital health company Health2Sync will work with Sanofi on digitising its range of insulin products in Japan, extending an earlier alliance in other markets.

News

Takeda bolsters data for dengue jab as regulatory reviews ro...

Takeda has reported positive new, long-term results in its pivotal trial of dengue fever vaccine TAK-003 that builds the case for the shot as regulators review marketing applications.

News

Sanofi furthers its digital ambitions with Paris accelerator

Sanofi has launched a new initiative in its drive to integrate digital technologies throughout its business, setting up an accelerator based in Paris that will serve as the lynchpin of the

Market Access

Combination pricing: access to the future of oncology treatm...

Combination therapies are fast becoming the cornerstone of cancer treatment: not just in the UK, but across the world.

News

SEC accuses former AstraZeneca exec of insider trading

The US Securities and Exchange Commission has sued a former AstraZeneca executive over alleged insider trading in connection with its 2019 deal to acquire rights to Daiichi Sankyo's breast

Celebrations for ASMD community as EU clears Sanofi's Xenpoz...

Sanofi extends Health2Sync digital diabetes partnership to J...

Takeda bolsters data for dengue jab as regulatory reviews ro...

Sanofi furthers its digital ambitions with Paris accelerator

Combination pricing: access to the future of oncology treatm...

SEC accuses former AstraZeneca exec of insider trading

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

Sanofi

Editor's Picks